CRT (cardiac resynchronization therapy) known to be effective in reducing mortality due to heart failure and sudden cardiac death is also proven for its benefits to diabetic patients.
CRT, a contraption implanted into the body, is capable of resynchronising the contractions of the heart's ventricles by transmitting electrical impulses, so that blood is pumped with added efficiency. It is estimated that above 200,000 patients suffering heart failure from around the world, have been fitted with a CRT device.
Uta C. Hoppe, MD, Department of Medicine III, University of Cologne, Germany said,"From previous CARE-HF data, we already knew that CRT improves survival in heart failure patients. With these new data, we now have proof that CRT is beneficial in heart failure patients with different co-morbidities, including those at risk of sudden cardiac death and patients with diabetes."
Previous studies had shown that CRT had brought down the risk of death due to heart failure by almost 45% and sudden cardiac death by 53%. Further studies showed that the benefits could be extended to patients with diabetes as well, as it brought down the mortality rate by almost 39%.